Title of article
Discovery of amido-benzisoxazoles as potent c-Kit inhibitors
Author/Authors
Roxanne K. Kunz، نويسنده , , Shannon Rumfelt، نويسنده , , Ning Chen، نويسنده , , Dawei Zhang، نويسنده , , Andrew S. Tasker، نويسنده , , Roland Bürli، نويسنده , , Randall Hungate، نويسنده , , Violeta Yu، نويسنده , , Yen Nguyen، نويسنده , , Douglas A. Whittington، نويسنده , , Kristin L. Meagher، نويسنده , , Matthew Plant، نويسنده , , Yanyan Tudor، نويسنده , , Michael Schrag، نويسنده , , Yang Xu، نويسنده , , Gordon Y. Ng، نويسنده , , Essa Hu، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2008
Pages
3
From page
5115
To page
5117
Abstract
Deregulation of the receptor tyrosine kinase c-Kit is associated with an increasing number of human diseases, including certain cancers and mast cell diseases. Interference of c-Kit signaling with multi-kinase inhibitors has been shown clinically to successfully treat gastrointestinal stromal tumors and mastocytosis. Targeted therapy of c-Kit activity may provide therapeutic advantages against off-target effects for non-oncology applications. A new structural class of c-Kit inhibitors is described, including in vitro c-Kit potency, kinase selectivity, and the observed binding mode.
Keywords
Receptor tyrosine kinase , mast cells , c-kit
Journal title
Bioorganic & Medicinal Chemistry Letters
Serial Year
2008
Journal title
Bioorganic & Medicinal Chemistry Letters
Record number
799961
Link To Document